These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
550 related articles for article (PubMed ID: 19116962)
1. Inclusion of glucocorticoids in recommendations for the use of nonbiologic and biologic disease-modifying antirheumatic drugs in rheumatoid arthritis: Comment on the article by Saag et al. van Tuyl LH; Lems WF; Voskuyl AE; Dijkmans BA; Boers M; Kerstens PJ Arthritis Rheum; 2009 Jan; 61(1):141-2; author reply 141-2. PubMed ID: 19116962 [No Abstract] [Full Text] [Related]
2. The 2008 American College of Rheumatology recommendations for the use of nonbiologic and biologic disease-modifying antirheumatic drugs in rheumatoid arthritis: where the rubber meets the road. Bathon JM; Cohen SB Arthritis Rheum; 2008 Jun; 59(6):757-9. PubMed ID: 18512712 [No Abstract] [Full Text] [Related]
3. [Recommendations from an expert group: drug therapy of rheumatoid arthritis]. Lakartidningen; 1992 May; 89(21):1923-6. PubMed ID: 1350802 [No Abstract] [Full Text] [Related]
4. Rheumatoid arthritis drug update. Johns Hopkins Med Lett Health After 50; 2008 May; 20(3):4-5, 7. PubMed ID: 18652033 [No Abstract] [Full Text] [Related]
5. Current treatments for rheumatoid arthritis. Kavanaugh A Am J Orthop (Belle Mead NJ); 2007 Mar; 36(3 Suppl):4-7. PubMed ID: 17491580 [No Abstract] [Full Text] [Related]
6. Effects of disease-modifying antirheumatic drug treatment on the expression of RANKL and osteoprotegerin in synovial tissue: comment on the article by Haynes et al. Catrina AI; Klareskog L Arthritis Rheum; 2008 Nov; 59(11):1685; author reply 1685-6. PubMed ID: 18975354 [No Abstract] [Full Text] [Related]
7. The use of glucocorticoids in preventing joint destruction: Comment on the review by Schett et al. Kirwan JR; Boers Msc M Arthritis Rheum; 2009 Apr; 60(4):1202-3; reply 1203-4. PubMed ID: 19333941 [No Abstract] [Full Text] [Related]
8. Disease-modifying antirheumatic drug use in the elderly rheumatoid arthritis patient. Ranganath VK; Furst DE Clin Geriatr Med; 2005 Aug; 21(3):649-69, viii. PubMed ID: 15911212 [TBL] [Abstract][Full Text] [Related]
9. Disease-modifying drugs in rheumatoid arthritis. Rahman A; Ahmed S; Underwood M Practitioner; 2001 Dec; 245(1629):1018-25. PubMed ID: 11771221 [No Abstract] [Full Text] [Related]
10. Emerging trends in diagnosis and treatment of rheumatoid arthritis. Birch JT; Bhattacharya S Prim Care; 2010 Dec; 37(4):779-92, vii. PubMed ID: 21050958 [TBL] [Abstract][Full Text] [Related]
11. Rheumatoid arthritis. Lorenzo M Foot Ankle Clin; 2007 Sep; 12(3):525-37, vii. PubMed ID: 17765843 [TBL] [Abstract][Full Text] [Related]
12. Oral glucocorticoids should be included in any recommendation for the use of nonbiologic and biologic disease-modifying antirheumatic drugs in the treatment of rheumatoid arthritis: comment on the article by Singh et al. Conn DL Arthritis Care Res (Hoboken); 2012 Oct; 64(10):1622-3; author reply 1623-4. PubMed ID: 23024030 [No Abstract] [Full Text] [Related]
13. Failure to report previously used drugs and dosages in pharmaceutical company-sponsored rheumatoid arthritis trials: comment on the article by Yocum et al. Parker CT; Rennie T Arthritis Rheum; 2004 Sep; 50(9):3051; author reply 3051-2. PubMed ID: 15457479 [No Abstract] [Full Text] [Related]
14. [Modern treatment of rheumatoid arthritis]. Surányi P Orv Hetil; 2005 Oct; 146(40):2059-65. PubMed ID: 16259334 [TBL] [Abstract][Full Text] [Related]
16. Drugs for rheumatoid arthritis. Treat Guidel Med Lett; 2005 Dec; 3(40):83-90. PubMed ID: 16299450 [No Abstract] [Full Text] [Related]
17. Complex treatment options for rheumatoid arthritis. Giaquinta D Manag Care Interface; 2001 Jul; 14(7):49-51. PubMed ID: 11481816 [No Abstract] [Full Text] [Related]
18. Rheumatoid arthritis. Current therapy for a highly treatable disease. Sherman JA Adv Nurse Pract; 2001 Dec; 9(12):28-30. PubMed ID: 12400351 [No Abstract] [Full Text] [Related]
19. Low-dose glucocorticoid therapy in rheumatoid arthritis: an obligatory therapy. Bijlsma JW; van der Goes MC; Hoes JN; Jacobs JW; Buttgereit F; Kirwan J Ann N Y Acad Sci; 2010 Apr; 1193():123-6. PubMed ID: 20398017 [TBL] [Abstract][Full Text] [Related]
20. [Advances in the drug therapy of rheumatoid arthritis]. Zeng Q; Liu J Zhonghua Nei Ke Za Zhi; 1997 Apr; 36(4):273-5. PubMed ID: 10374289 [No Abstract] [Full Text] [Related] [Next] [New Search]